BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design

Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

September 25, 2023 | News

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...

September 22, 2023 | News

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform ca...

September 21, 2023 | News

Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), h...

September 21, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized a...

September 20, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study

The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...

September 20, 2023 | News

Integrated DNA Technologies and Aldevron Partner to Provide CRISPR Components to Therapy Developers

Leading CRISPR gene editing companies Integrated DNA Technologies and Aldevron inked a new global distribution agreement to...

September 19, 2023 | News

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specifi...

September 19, 2023 | News

Stay Connected